Conference abstract · 27 Jul 2015
Conference abstractPublished 26 Aug 2021
Could we edit our next generations?
Teaching Assistant and researcher at St. John's University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lots of arguments about CRISPR/Cas9 were being set, especially relating to its usage in genome editing and its applications in human embryos and how to select the targeted embryos and discard the unfavorable ones. Especially after the usage of CRISP/Cas9 to engineer HIV-resistant babies by Jiankui that ended by being jailed for three years. CRISPR/Cas9 that was first announced in 1987, by Japanese scientists, Ishino, but not got widely used in clinical studies until 2016. Most of which are focusing on the ex vivo genome editing. In this review we would we would highlight the usage of CRISPR/Cas9 genome editing tool related to cancer, especially for Neuroblastoma Tumorigenicity. Previous descriptions of the history, functionality, and applications of CRISPR/Cas9 systems will be mentioned first, followed by the design strategies and most significant results. The last part of this review includes general comparison between CRISPR/Cas9 and other genome editing tools and its efficiency its therapeutics role in clinical trials. Clustered regularly interspaced short palindromic repeat, CRISPR/ Cas 9, which is the natural immune system of Streptococcus bacteria against viral infection. CRISPR/Cas9 system got activated by sending viral DNA into their designated bacteria. Like any organism if the bacteria would survive the infection, the bacterium would allow the insertion of DNA into its genome. This would act like a memory to enhance the immune system to respond if further attack had occurred. CRISPRs have been first recognized in E. coli in 1987 with the aid of a Japanese scientist, Yoshizumi Ishino, and his team, who by chance cloned an uncommon collection of repeated sequences interspersed with spacer sequences. This was done for studying a gene liable for the conversion of alkaline phosphatase. The proof for the lifestyles of CRISPRs resulted from the fast accumulation of archaeal and bacterial genome sequences on the give up of the 1990s. Their better occurrence in archaea and their presence in thermophilic microorganism advised that they is probably related to specific conditions. However, because of the dearth of enough DNA collection data, the characteristic of those arrays remained a mystery. In 1993, researchers led with the aid of using J.D. van Embden within side the Netherlands found that extraordinary lines of Mycobacterium tuberculosis had extraordinary spacer sequences among the DNA repeats. They characterized M. tuberculosis lines primarily based totally on their spacer sequences, a method called spoligotyping.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 30 Jun 2025
The Scientific Advances and Ethical Implications of Next Generation Genome Editing Technologies in Human Therapeutics and Global Sustainability
Letter · 1 Mar 2011
Mitochondrial plasmid: could this be the next hit for genetic engineering?
Editorial · 12 Dec 2025
Gene Editing for Drug Development: The Role of CRISPR in Next-Generation Therapeutics
Perspective · 24 Sep 2021
Understanding How Researchers could Generate Ovarian Follicles from Mouse Stem Cells
More from this journal
The newest in Molecular and Genetic Medicine.
Short communication · 29 Dec 2025
Chromatin Remodeling: Cancer, Development, and Therapeutics
Brief report · 29 Dec 2025
Multi-Omics: Accelerating Biomarker Discovery and Disease Insights
Short communication · 29 Dec 2025
RNA Editing: a Role in Health and Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular and Genetic Medicine
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Alshymaa Y.Hassan”

